FourThought Financial’s PhenomeX Inc. Common Stock CELL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-1,108
Closed -$49K 1603
2021
Q2
$49K Buy
1,108
+374
+51% +$17.3K 0.01% 714
2021
Q1
$36K Buy
+734
New +$50K 0.01% 771

Other funds holding CELL

FourThought Financial's CELL Position: Q3 2021 in Review

FourThought Financial sold out of PhenomeX Inc. Common Stock (CELL) in Q3 2021, closing a stake of 1,108 shares — an estimated $49K sold.

FourThought Financial first reported a position in CELL in Q1 2021 and held it in 2 quarters. The position peaked at $49K in Q2 2021. 137 funds tracked by Wall St. Rank hold CELL as of Q3 2021.

  • FourThought Financial reported no remaining PhenomeX Inc. Common Stock position as of Q3 2021 after selling out during the quarter.
  • FourThought Financial sold 1,108 PhenomeX Inc. Common Stock shares in Q3 2021, an estimated $49K.
  • FourThought Financial first reported a position in PhenomeX Inc. Common Stock in Q1 2021 and held it in 2 quarters.
  • FourThought Financial's PhenomeX Inc. Common Stock position peaked at $49K in Q2 2021.
  • 137 funds tracked by Wall St. Rank held PhenomeX Inc. Common Stock as of Q3 2021.

Based on FourThought Financial's 13F filing for Q3 2021, filed 12 Nov 2021.